logo
Menu
  • Home
  • Company
    • Senior Management
    • Board of Directors
    • Careers
  • Pipeline
    • Levosimendan
      • Clinical Trials
    • Oxycyte
  • Research
    • LEVO-CTS Trial
      • LEVO-CTS Overview
      • LEVO-CTS Team
      • LEVO-CTS Training and Resources
    • Publications
      • Levosimendan in Cardiac Surgery
  • Investors
    • Corporate Profile
    • Press Releases
    • Corporate Governance
    • Board of Directors
    • Senior Management
    • Stock Information
    • Annual Reports
    • Analyst Coverage
    • SEC Filings
    • Events and Presentations
    • Investor Contacts
    • Tearsheet
    • Email Alerts
  • Media
    • Press Releases
  • Contact

Press Releases

  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • «
  • ←
  • 4
  • 5
  • 6
09/22/14 8:30 am EDT
Tenax Therapeutics Announces First Patients Enrolled in Phase 3 LEVO-CTS Clinical Trial of Levosimendan
09/19/14 8:30 am EDT
Tenax Therapeutics to Provide Corporate Update and Discuss First Quarter Fiscal Year 2015 Financial Results on September 24, 2014
  • Home
  • Company
    • Senior Management
    • Board of Directors
    • Careers
  • Pipeline
    • Levosimendan
      • Clinical Trials
    • Oxycyte
  • Research
    • LEVO-CTS Trial
      • LEVO-CTS Overview
      • LEVO-CTS Team
      • LEVO-CTS Training and Resources
    • Publications
      • Levosimendan in Cardiac Surgery
  • Investors
    • Corporate Profile
    • Press Releases
    • Corporate Governance
    • Board of Directors
    • Senior Management
    • Stock Information
    • Annual Reports
    • Analyst Coverage
    • SEC Filings
    • Events and Presentations
    • Investor Contacts
    • Tearsheet
    • Email Alerts
  • Media
    • Press Releases
  • Contact
© 2020 Tenax Therapeutics. All rights reserved.